Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725530 · ClinicalTrials.gov registry record · NA
Evaluation of Deposits on Contact Lenses Worn Extended Wear
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00725530 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 54 participants.
The verdict
NCT00725530, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study was to measure lipid deposits on commercially marketed contact lenses when worn on an extended wear (overnight) basis for 7 days.
Interventions
- DEVICE balafilcon A contact lens (PureVision)
- DEVICE etafilcon A contact lens (Acuvue2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00725530
The ClinicalTrials.gov registry entry for NCT00725530 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which balafilcon A contact lens (PureVision) is the first listed.
NCT00725530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00725530 about?
NCT00725530 is a clinical study titled "Evaluation of Deposits on Contact Lenses Worn Extended Wear". The purpose of this study was to measure lipid deposits on commercially marketed contact lenses when worn on an extended wear (overnight) basis for 7 days.
What is the current status of trial NCT00725530?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2008-03. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00725530?
The interventions under investigation include: balafilcon A contact lens (PureVision) (DEVICE), etafilcon A contact lens (Acuvue2) (DEVICE).
Who is sponsoring clinical trial NCT00725530?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.